Track topics on Twitter Track topics that are important to you
19 Hartum Street, P.O. Box 45158
BioLineRx has launched a late-stage trial with about 180 participants to determine the efficacy of BL-8040 plus granulocyte c -More-
In this episode of PharmaTelevision News Review, filmed in Amsterdam at BioEurope Spring 2012, Fintan Walton talks to David Malek, Vice Preident of Business Development of BioLineRx.
BioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a clinical-stage biopharmaceutical company focused on oncology and immunology, announced today positive overall survival data from the long-term Read mo...
In this interview filmed at BIO Europe 2013 in Vienna, Paul Larsmon chats to David Malek, Vice President, Business Development at BioLine RX. BioLineRx is a clinical-stage, publicly-traded (NASDAQ/ TA...
BioLineRx's ultimate mission is to improve the health of people throughout the world with compounds that make for better and longer lives. Founded in 2003 by leaders in the Israeli life-sciences secto...
BioLineRx Ltd. is a publicly traded (TASE:BLRX) biopharmaceutical development company based in Jerusalem, Israel. BioLineRx is dedicated to identifying, in-licensing and developin...
BioLineRx Ltd. is a publicly-traded biopharmaceutical development company. It is dedicated to building a portfolio of products for unmet medical needs or with advantages over curr...
We have published hundreds of BioLineRx, Ltd. news stories on BioPortfolio along with dozens of BioLineRx, Ltd. Clinical Trials and PubMed Articles about BioLineRx, Ltd. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of BioLineRx, Ltd. Companies in our database. You can also find out about relevant BioLineRx, Ltd. Drugs and Medications on this site too.
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...